Systemic Treatments for Women with Breast Cancer: Outcome with Relation to Screening for the Disease
Overview
Affiliations
Early detection and proper care of breast cancer are currently the best available approaches to the treatment of patients with the disease. In countries with a breast cancer screening programme, there has been a demonstrated reduction in breast cancer-related mortality. Such reduction has also been observed in Switzerland, a country in which no national programme of screening is available. Although there is no doubt that early diagnosis might have had a major role in reducing breast cancer mortality the magnitude of this effect is unknown. Research with tailored approaches on alternative imaging for early detection of breast cancer in high-risk women and on treatments offered according to proper criteria of responsiveness to therapies is warranted.
Overexpression and translocation of dynamin 2 promotes tumor aggressiveness in breast carcinomas.
Sajed R, Saeednejad Zanjani L, Rahimi M, Mansoori M, Zarnani A, Madjd Z EXCLI J. 2020; 19:1423-1435.
PMID: 33250680 PMC: 7689243. DOI: 10.17179/excli2020-2762.
Liu D, Chang C, Gold D, Goldenberg D Oncotarget. 2015; 6(6):4274-85.
PMID: 25595893 PMC: 4414189. DOI: 10.18632/oncotarget.2760.
Bhutia S, Das S, Azab B, Menezes M, Dent P, Wang X Int J Cancer. 2013; 133(11):2726-36.
PMID: 23720015 PMC: 4334374. DOI: 10.1002/ijc.28289.
Protein biomarkers for the early detection of breast cancer.
Misek D, Kim E Int J Proteomics. 2011; 2011:343582.
PMID: 22084684 PMC: 3195294. DOI: 10.1155/2011/343582.
Nanoparticle technology: Addressing the fundamental roadblocks to protein biomarker discovery.
Luchini A, Longo C, Espina V, Petricoin 3rd E, Liotta L J Mater Chem. 2010; 19(29):5071-5077.
PMID: 20585471 PMC: 2888266. DOI: 10.1039/b822264a.